Market cap
$300.9M

Kyverna Therapeutics Inc. (KYTX) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. In the last 30 days Quantisnow tracked 9 wire items for KYTX, including 5 press releases and news items, 2 SEC filings and 1 earnings update. The most recent was published Nov 16, 2026.

KYTX rankings

Financial highlights

Full financials
Net income, TTM
-$157.79M
Cash
$31.82M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks28+50%
2026-05-24: 52026-05-31: 22026-06-07: 02026-06-14: 02026-06-21: 12026-06-28: 02026-07-05: 12026-07-12: 02026-07-19: 02026-07-26: 22026-08-02: 02026-08-09: 42026-08-16: 02026-08-23: 02026-08-30: 12026-09-06: 02026-09-13: 02026-09-20: 22026-09-27: 02026-10-04: 12026-10-11: 02026-10-18: 32026-10-25: 02026-11-01: 12026-11-08: 42026-11-15: 1
2026-05-242026-11-15
Mix1390d
  • Other7(54%)
  • SEC Filings3(23%)
  • Earnings2(15%)
  • 13D/G1(8%)
Activity · 52 weeks9251 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

KYTX FAQ

9 questions
  • What is the latest news on KYTX?
    In the last 30 days Quantisnow tracked 9 wire items for KYTX: 5 press releases and news items, 2 SEC filings, 1 earnings update and 1 13D/G filing. The most recent was published on November 16, 2026.
  • Is KYTX profitable?
    No. Kyverna Therapeutics Inc. reported a net loss of $157.79M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does KYTX have?
    Kyverna Therapeutics Inc. reported $31.82M in cash and cash equivalents and $24.96M of debt on its most recent balance sheet in SEC filings.
  • Where does KYTX stock trade?
    Kyverna Therapeutics Inc. (KYTX) is listed on NASDAQ.
  • What sector and industry is KYTX in?
    Kyverna Therapeutics Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
  • When did Kyverna Therapeutics Inc. go public?
    Kyverna Therapeutics Inc. (KYTX) completed its IPO in 2024.
  • What are analysts saying about KYTX?
    Across the last 8 analyst actions on Kyverna Therapeutics Inc., there was 1 upgrade and 0 downgrades. The most recent action was from William Blair: Outperform on 2025-08-20.
  • What companies are similar to KYTX?
    Notable peers in the same industry include MRNA (Moderna Inc.), GILD (Gilead Sciences Inc.), BIIB (Biogen Inc.), RVMD (Revolution Medicines Inc.), AMGN (Amgen Inc.). Compare KYTX side-by-side with any of them on Quantisnow.
  • How can I track KYTX on Quantisnow?
    Quantisnow aggregates Kyverna Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KYTX to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change